{"product_id":"covetrus-swot-analysis","title":"Covetrus SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Company’s Strategic Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eCovetrus combines a strong recurring-revenue model and integrated supply-chain capabilities with growing digital tools for veterinary practices, but it faces margin pressure, competition, and regulatory risks that could affect scalability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Veterinary Ecosystem\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCovetrus offers an end-to-end veterinary platform combining practice management software, supply chain distribution, and prescription fulfillment, enabling clinics to run clinical, inventory, and billing workflows with one vendor.\u003c\/p\u003e\n\u003cp\u003eThis vertical integration raised recurring revenue: in 2024 Covetrus reported $1.7B in product and services revenue, which tightens clinic dependence and raises switching costs through synced records and automated reorders.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket-Leading Software Suite\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCovetrus holds a dominant position via Pulse and eVetPractice, two cloud-based practice management systems used by over 15,000 clinics worldwide as of Q4 2025, handling clinical records, billing, inventory, and scheduling.\u003c\/p\u003e\n\u003cp\u003eThese platforms drive recurring SaaS revenue—about $420 million in 2024 services revenue—and anchor digital transformation for independent and corporate groups, reducing admin time by ~30% per clinic in vendor studies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCovetrus runs a global logistics network serving 100+ countries and over 150,000 veterinary customers, enabling on-time delivery of pharmaceuticals and clinical supplies; this scale supported $3.2B revenue in 2024 and boosts negotiating leverage with manufacturers for better purchase terms.\u003c\/p\u003e\n\u003cp\u003eThe company manages cold-chain logistics and regulatory complexity across markets, reducing spoilage and compliance fines—Covetrus reported a 98% on-time fill rate in 2024—creating a barrier versus smaller regional distributors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData-Driven Prescription Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCovetrus’s data-driven prescription management lets clinics recapture revenue via home delivery; in 2024 the pharmacy segment grew revenue ~12%, showing demand for remote fulfillment.\u003c\/p\u003e\n\u003cp\u003eUsing analytics to track compliance and automate refills, Covetrus reports improved adherence and fewer missed doses, boosting patient outcomes and lowering follow-up visits.\u003c\/p\u003e\n\u003cp\u003eThis proactive pharmacy model increases clinic prescription revenue and recurring margin, supporting practice cash flow and profitability.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHome delivery drives ~12% pharmacy revenue growth (2024)\u003c\/li\u003e\n\u003cli\u003eAutomated refills raise adherence and cut missed-dose visits\u003c\/li\u003e\n\u003cli\u003eImproves clinic recurring revenue and cash flow\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Private Equity Backing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic private equity backing from Clayton, Dubilier \u0026amp; Rice and TPG Capital gives Covetrus deep capital and operational expertise, enabling multi-year tech investments and bold M\u0026amp;A without public-market quarterly pressure.\u003c\/p\u003e\n\u003cp\u003eThe partners’ financial flexibility funded Covetrus’s 2024 acquisition spree and supports digital initiatives and global expansion; combined PE dry powder exceeded $150 billion in 2024, easing large-scale financing.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLong-term capital for tech and M\u0026amp;A\u003c\/li\u003e\n\u003cli\u003eNo quarterly public reporting pressure\u003c\/li\u003e\n\u003cli\u003eSupports large digital projects and global growth\u003c\/li\u003e\n\u003cli\u003eBacked by PE firms with \u0026gt;$150B dry powder (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCovetrus: $3.2B vet platform—15k+ clinics, 150k customers, recurring SaaS \u0026amp; 98% fill rate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCovetrus’s integrated vet platform (Pulse, eVetPractice) drives recurring SaaS + services: $1.7B product\/services and $420M services in 2024, \u0026gt;15,000 clinics (Q4 2025), 150,000 customers across 100+ countries, $3.2B total revenue (2024), 98% on-time fill rate, pharmacy +12% growth (2024); PE backing (CD\u0026amp;R, TPG) with \u0026gt;$150B dry powder enables M\u0026amp;A and tech investment.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue (total)\u003c\/td\u003e\n\u003ctd\u003e$3.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct \u0026amp; services (2024)\u003c\/td\u003e\n\u003ctd\u003e$1.7B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices\/SaaS (2024)\u003c\/td\u003e\n\u003ctd\u003e$420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinics (Q4 2025)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;15,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers \/ Countries\u003c\/td\u003e\n\u003ctd\u003e150,000 \/ 100+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time fill rate (2024)\u003c\/td\u003e\n\u003ctd\u003e98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacy growth (2024)\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePE dry powder (2024)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$150B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a strategic overview of Covetrus’s internal strengths and weaknesses and the external opportunities and threats shaping its competitive position in the animal-health and veterinary supply market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise Covetrus SWOT matrix for rapid strategic alignment across veterinary channels, easing stakeholder briefings and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSubstantial Debt Obligations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFollowing its 2022 take‑private, Covetrus carries roughly $1.8 billion of long‑term debt on the balance sheet; servicing costs rose as U.S. benchmark rates climbed, pushing interest expense above $160 million in FY2024. Higher rates through 2024–2025 have squeezed free cash flow, likely constraining R and D and product investment. This leverage raises bankruptcy and liquidity risk in a downturn and reduces flexibility versus lower‑debt peers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy System Integration Hurdles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCovetrus was formed by the 2022 merger of Henry Schein Animal Health and Vets First Choice, leaving a tangle of legacy IT stacks; as of Q4 2024 IT consolidation lagged, with management reporting a 15–20% CRM integration gap across markets.\u003c\/p\u003e\n\u003cp\u003ePartial harmonization improved order routing and inventory accuracy, cutting fulfillment errors by 9% in 2024, but full platform sync across 25+ countries remains incomplete.\u003c\/p\u003e\n\u003cp\u003eInconsistent UX on older modules correlated with a 4% net revenue retention drag in 2024 and higher churn among small clinics, per company disclosures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow-Margin Distribution Dependence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eA large share of Covetrus revenue—about 60% in FY2024 revenue of $3.6B—comes from third‑party product distribution, which yields materially lower gross margins (~18%) versus its SaaS\/technology segment (~65%). This high-volume, low-margin mix makes earnings sensitive to fuel and logistics swings: U.S. diesel rose ~25% year‑over‑year in 2022–23, squeezing distribution margins. Moving mix to higher‑margin SaaS is gradual and needs continual product innovation and sales ramp time.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Operational Complexity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eManaging Covetrus’s global supply chain plus a software development arm creates organizational friction; in 2024 Covetrus reported $3.1B revenue split across distribution and tech services, forcing trade-offs in capital and talent.\u003c\/p\u003e\n\u003cp\u003eThe dual business model needs distinct expertise, causing misaligned priorities between logistics and product teams and slowing product-to-market timing in a fast-growing pet health market (global pet care market ~$325B in 2024).\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eDual model: $3.1B revenue split\u003c\/li\u003e\n\u003cli\u003eSkill gap: logistics vs. software\u003c\/li\u003e\n\u003cli\u003eDecision lag: slower time-to-market\u003c\/li\u003e\n\u003cli\u003eMarket pressure: $325B pet care 2024\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographic Concentration in North America\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpdespite having a global footprint covetrus reported about of revenue from north america form concentrating profit and cash flow in the us market raising exposure to economic swings regulatory moves such as medicare shifts.\u003e\u003cpdiversification into asia and latin america lags: international revenue grew cagr versus in north leaving expansion slower than many analysts expected.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~78% revenue from North America (2024)\u003c\/li\u003e\n\u003cli\u003eInternational revenue CAGR ~3% (2021–2024)\u003c\/li\u003e\n\u003cli\u003eHigher sensitivity to US regulation and macro shocks\u003c\/li\u003e\n\u003cli\u003eSlower-than-expected Asian\/Latin American expansion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pdiversification\u003e\u003c\/pdespite\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Debt, Fragile Growth: 78% NA Revenue, Heavy Distribution, Margin \u0026amp; IT Strain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh leverage: $1.8B long‑term debt; interest expense \u0026gt;$160M FY2024, pressuring FCF. Legacy IT fragmentation: 15–20% CRM integration gap; 4% NRR drag in 2024. Revenue mix weak: 60% low‑margin distribution (≈18% gross); SaaS ~65% gross. Geographic concentration: ~78% revenue North America; intl CAGR ~3% (2021–2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLong‑term debt\u003c\/td\u003e\n\u003ctd\u003e$1.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInterest expense\u003c\/td\u003e\n\u003ctd\u003e$160M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$3.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution share\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNA revenue share\u003c\/td\u003e\n\u003ctd\u003e78%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eCovetrus SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get. Purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003cp\u003eThis is a real excerpt from the complete document. Once purchased, you’ll receive the full, editable version.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752481272185,"sku":"covetrus-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/covetrus-swot-analysis.png?v=1772241557","url":"https:\/\/growthsharematrix.com\/products\/covetrus-swot-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}